Showing results (21-30 of 1,054) with videos related to
Sort By:
Pageof 106
Alzheimer'S & Dementia (New York, N. Y.)|March 31, 2022
Impact of non-binding FDA guidances on primary endpoint selection in Alzheimer's disease trialsJeffrey C Yu, Jakub P Hlávka, Elizabeth Joe, et al.Alzheimer'S & Dementia (New York, N. Y.)|April 13, 2022
Preclinical evaluation of drug treatment options for sleep-related epileptiform spiking in Alzheimer's diseaseNanxiang Jin, Irina Gureviciene, Aysu Naz Atalay, et al.Alzheimer'S & Dementia (New York, N. Y.)|April 13, 2022
Effects of water-soluble mangosteen extract on cognitive function and neuropsychiatric symptoms in patients with mild to moderate Alzheimer's disease (WECAN-AD): A randomized controlled trialWeerasak Muangpaisan, Puvanant Wiputhanuphongs, Nattapon Jaisupa, et al.Alzheimer'S & Dementia (New York, N. Y.)|April 13, 2022
Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's diseaseXiang Zou, Yifan Yuan, Yujun Liao, et al.Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
Bioinformatics pipeline to guide late-onset Alzheimer's disease (LOAD) post-GWAS studies: Prioritizing transcription regulatory variants within LOAD-associated regionsMichael W Lutz, Ornit Chiba-FalekAlzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
The impact of hearing impairment and hearing aid use on progression to mild cognitive impairment in cognitively healthy adults: An observational cohort studyMagda Bucholc, Sarah Bauermeister, Daman Kaur, et al.Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registersCaroline Holm Nørgaard, Sarah Friedrich, Charlotte Thim Hansen, et al.Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer's diseasePradeep J Nathan, S Babli Millais, Alex Godwood, et al.Alzheimer'S & Dementia (New York, N. Y.)|August 11, 2018
Intranasal rifampicin for Alzheimer's disease preventionTomohiro Umeda, Akiko Tanaka, Ayumi Sakai, et al.Alzheimer'S & Dementia (New York, N. Y.)|December 16, 2022
Models of depressive pseudoamnestic disorderJongwoo Choi, Seonjoo Lee, Jeffrey N Motter, et al.Pageof 106